IRCT201205305113N3CompletedPhase 3
The effect of N-Acetyle Systeine in preventing contrast induced nephropathy in patients with different stages of chronic kidney diseases
ephrology Research Center, Tehran University of Medical Sciences0 sites549 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 549
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 99 years (—)
- Sex
- All
Inclusion Criteria
- •age more than 18; serum creatinine more than 1.5 mg/ dl ; not having AKI; not receiving nephrotoxine since 1 week before entering the study; signing the consent.
- •Exclusion criteria: the patients who undergo surgery in less than 1 week of contrast exposure; the patients who are in need for a nephrotoxine in less than five days after contrast exposure; the patients who need repeated contrast administration in less than five days of first exposure
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
The effect of N-acetyl cysteine in preventing mucositis in patients undergoing bone marrow transplantatioCondition 1: Mucositis (oral). Condition 2: AML. Condition 3: ALL. Condition 4: MDS.Oral mucositis (ulcerative)Acute myeloblastic leukaemiaAcute lymphoblastic leukaemiaMyelodysplastic syndromesIRCT201303301030N13Hematology Oncology and SCT Research Center64
Completed
Not Applicable
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecifiedIRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60
Completed
Not Applicable
use of acetyl cystein in prevention of anti-TB drug induced hepatitisdrug induced hepatits.Toxic liver disease with hepatic necrosisIRCT201205259855N1Arak University of Medical sciences
Completed
Phase 2
Evaluation of the protective effect of N-Acetyle-Cysteine versus placebo on the heart of diabetic patients undergoing CABGCoronary artery bypass graft.Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectorisI25.70IRCT20120215009014N202Hamedan University of Medical Sciences240
Completed
Phase 2
The role of N-acetyl Cysteine in the eradication of H.PyloriFunctional dyspepsiaIRCT20141209020258N103Arak University of Medical Sciences167